Biotech · Private company
Genervon Biopharmaceuticals, LLC
Track this companyFree. Adds Genervon Biopharmaceuticals, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- GM602Phase 2 · StrokeClinicalTrials.gov · fetched Nov 12, 2026
- GM604Phase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- GM608Phase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)PHASE2 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01854294 · fetched Nov 12, 2026
- Phase 2A Study of GM 608 in Mild to Moderate Parkinson DiseasePHASE2 · COMPLETED · started Jun 1, 2013ClinicalTrials.gov NCT01850381 · fetched Nov 12, 2026
- Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 HoursPHASE2 · COMPLETED · started Mar 8, 2011ClinicalTrials.gov NCT01221246 · fetched Nov 12, 2026